Free Account Opening + AMC Free Demat
Loading...

Earum Pharmaceuticals Rights Issue 2023 vs Libas Consumer Products Rights Issue 2022

Comparision between Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022. Earum Pharmaceuticals Rights Issue 2023 is listed on BSE while Libas Consumer Products Rights Issue 2022 is listed on NSE.

  Earum Pharmaceuticals Limited Libas Consumer Products Limited
Logo Earum Pharmaceuticals Rights Issue 2023 Logo Libas Consumer Products Rights Issue 2022 Logo
Listing At BSE NSE
Terms of Payment

Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call.

Entitlement 4 Equity Shares for every 1 Equity Shares held on the Record Date 1 Equity Shares for every 2 Equity Shares held on the Record Date
Application Form Application Form Application Form
Letter of Offer Letter of Offer Letter of Offer
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Lead Managers Axis Bank Limited Sarthi Capital Advisors Private Limited

Rights Issue Size and Price

The issue size of Earum Pharmaceuticals Rights Issue 2023 rights issue is ₹49.34 Crores, whereas Libas Consumer Products Rights Issue 2022 rights issue size is ₹18.52 Crores.

  Earum Pharmaceuticals Limited Libas Consumer Products Limited
Issue Size 24,67,16,400 shares 88,20,000 shares
Issue Size (Amount) ₹49.34 Crores ₹18.52 Crores
Issue Price ₹2 per share ₹21 per share
Face Value ₹2 per share ₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Earum Pharmaceuticals Rights Issue 2023 is Apr 10, 2023 while record date of Libas Consumer Products Rights Issue 2022 is Sep 16, 2022.

  Earum Pharmaceuticals Limited Libas Consumer Products Limited
Record Date Apr 10, 2023 Sep 16, 2022
Credit of Rights Entitlements Apr 26, 2023 Sep 26, 2022
Bid/Offer Opens On May 02, 2023 Sep 27, 2022
Renunciation of Rights Entitlements May 26, 2023 Oct 03, 2022
Bid/Offer Closes On May 31, 2023 Oct 07, 2022
Deemed Date of Allotment Jun 20, 2023 Oct 18, 2022
Credit Date Jun 21, 2023 Oct 20, 2022
Listing Date Jun 26, 2023 Oct 25, 2022

Financials details

Comparison of Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

  Earum Pharmaceuticals Limited Libas Consumer Products Limited
Financial
Earum Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and Surplus
31-Mar-2036.1657.381.828.25
31-Mar-2127.8750.020.098.33
31-Mar-2228.7928.742.224.39
Amount in ₹ Crore
Libas Consumer Products Limited Financial Information (Restated)
Period EndedTotal RevenueProfit After Tax
31-Mar-2135.54-1.63
31-Mar-2246.722.56
Amount in ₹ Crore

Comments

Add a public comment...